Lack of adverse clopidogrel-atorvastatin clinical interaction -: Reply

被引：0
|
作者：
Wienbergen, H
Senges, J
机构：
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2004年 / 93卷 / 05期
关键词：
D O I：
10.1016/j.amjcard.2003.08.081
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：669 / 670
页数：2
相关论文
共 50 条
  • [41] Interaction between clopidogrel and proton pump inhibitors: Literature to clinical practice
    Hadi, Muhammad Abdul
    Lip, Tan Chong
    AUSTRALASIAN MEDICAL JOURNAL, 2011, 4 (06): : 281 - 282
  • [42] Peptic Disease: A Confounding Factor for Proton Pump Inhibitor-Clopidogrel Interaction? Reply
    Gaglia, Michael A.
    Waksman, Ron
    AMERICAN JOURNAL OF CARDIOLOGY, 2010, 106 (02): : 295 - 295
  • [43] Comment: Drug-Drug Interaction Between Clopidogrel and the Proton Pump Inhibitors REPLY
    Norgard, Nicholas B.
    Wall, Geoffrey C.
    ANNALS OF PHARMACOTHERAPY, 2010, 44 (01) : 226 - 227
  • [44] Impact of Female Sex on Lipid Lowering, Clinical Outcomes, and Adverse Effects in Atorvastatin Trials
    Hsue, Priscilla Y.
    Bittner, Vera A.
    Betteridge, John
    Fayyad, Rana
    Laskey, Rachel
    Wenger, Nanette K.
    Waters, David D.
    AMERICAN JOURNAL OF CARDIOLOGY, 2015, 115 (04): : 447 - 453
  • [45] Clopidogrel in patients with acute coronary syndromes: Learning from clinical practice - In reply
    Tricoci, Pierluigi
    Roe, Matthew T.
    Peterson, Eric D.
    ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (20) : 2293 - 2293
  • [46] LACK OF CLINICAL INTERACTION EFFECTS BETWEEN TAMSULOSIN AND ENALAPRIL
    STARKEY, LP
    TRENGA, C
    MIYAZAWA, Y
    ITO, Y
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 57 (02) : 166 - 166
  • [47] Lack of Robust Prognostic Biomarkers for Immunotherapy in Breast Cancer-Adverse Ev Reply
    Adams, Sylvia
    Mittendorf, Elizabeth A.
    JAMA ONCOLOGY, 2019, 5 (11) : 1640 - 1640
  • [48] Atorvastatin-Green Tea Interaction: Possible Mechanisms are Complicated, But Clinical Relevance is Not?
    Misaka, Shingen
    Shimomura, Kenju
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2020, 45 (03) : 423 - 425
  • [49] Approaches to management of rhabdomyolysis as the adverse effect of drug interaction between atorvastatin and sacubitril/valsartan: a case report
    Siew, Kelvin Shenq Woei
    Hafidz, Muhammad Imran Abdul
    Zaidan, Fatimah Zahrah Binti Mohd
    bin Hadi, Mohd Firdaus
    EUROPEAN HEART JOURNAL-CASE REPORTS, 2022, 6 (02)
  • [50] CLINICAL VALUE OF INTERACTION OF CLOPIDROGREL AND ATORVASTATIN IN RUSSIAN PATIENTS WITH ACUTE CORONARY SYNDROME
    Bunyatyan, V
    Kukes, I
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 : 69 - 69
12345